재무회계 제약산업 재무분석-동아제약, 광동제약, 유한양행(영문)

재무회계 제약산업 재무분석-동아제약, 광동제약, 유한양행(영문)

[재무회계] 제약산업 재무분석-동아제약, 광동제약, 유한양행(영문).ppt

목차 Introduction Profitability ROE Net profit margin Stability Debt- to-equity Worth index EPS DIVIDEND YIELD ACTIVITY Conclusion INVENTORY TURNOVER 본문 It is very difficult for new company to get into pharmacy industry This industry is attractive for us Introduction -DONG-A Dong-A Pharmaceutical is the leading pharmaceutical company in Korea. Dong-A s competitive advantage arises first and foremost from its continuous focus on R&D. Introduction KWANG DONG Kwang Dong first started serving the people 48 years ago with the goal of providing scientific benefits of the Oriental medicine. Financially healthy and strong competitive edge through constant and sizable R&D investment and updated IT system. 키워드 제약, 동아제약, 유한양행, 재무분석, 재무회계